You can:
Name | Alpha-2B adrenergic receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | ADRA2B |
Synonym | alpha2-C2 alpha2B alpha2B-adrenoceptor Alpha-2BAR alpha-2B adrenoreceptor [ Show all ] |
Disease | Neuropathic pain Alcohol use disorders |
Length | 450 |
Amino acid sequence | MDHQDPYSVQATAAIAAAITFLILFTIFGNALVILAVLTSRSLRAPQNLFLVSLAAADILVATLIIPFSLANELLGYWYFRRTWCEVYLALDVLFCTSSIVHLCAISLDRYWAVSRALEYNSKRTPRRIKCIILTVWLIAAVISLPPLIYKGDQGPQPRGRPQCKLNQEAWYILASSIGSFFAPCLIMILVYLRIYLIAKRSNRRGPRAKGGPGQGESKQPRPDHGGALASAKLPALASVASAREVNGHSKSTGEKEEGETPEDTGTRALPPSWAALPNSGQGQKEGVCGASPEDEAEEEEEEEEEEEECEPQAVPVSPASACSPPLQQPQGSRVLATLRGQVLLGRGVGAIGGQWWRRRAQLTREKRFTFVLAVVIGVFVLCWFPFFFSYSLGAICPKHCKVPHGLFQFFFWIGYCNSSLNPVIYTIFNQDFRRAFRRILCRPWTQTAW |
UniProt | P18089 |
Protein Data Bank | N/A |
GPCR-HGmod model | P18089 |
3D structure model | This predicted structure model is from GPCR-EXP P18089. |
BioLiP | N/A |
Therapeutic Target Database | T41580 |
ChEMBL | CHEMBL1942 |
IUPHAR | 26 |
DrugBank | BE0000572 |
Name | Yohimbine |
---|---|
Molecular formula | C21H26N2O3 |
IUPAC name | methyl (1S,15R,18S,19R,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate |
Molecular weight | 354.45 |
Hydrogen bond acceptor | 4 |
Hydrogen bond donor | 2 |
XlogP | 2.9 |
Synonyms | KBio3_001031 17a-hydroxy-16a-methoxycarbonyl-yohimbane methyl (1S,15R,18S,19R,20S)-18-hydroxy-3,13-diazapentacyclo[11.8.0.0;{2,10}.0;{4,9}.0;{15,20}]henicosa-2(10),4,6,8-tetraene-19-carboxylate 65Y190 NCGC00025018-05 [ Show all ] |
Inchi Key | BLGXFZZNTVWLAY-SCYLSFHTSA-N |
Inchi ID | InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17-,18-,19+/m0/s1 |
PubChem CID | 8969 |
ChEMBL | CHEMBL15245 |
IUPHAR | 102 |
BindingDB | 50013515, 50203564 |
DrugBank | DB01392 |
Structure | |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
N/A | N/A | DrugBank | |
IC50 | 17.0 nM | DrugMatrix in vitro pharmacology data | ChEMBL |
Ki | 0.32 nM | PMID2172775 | BindingDB |
Ki | 0.37 nM | PMID1353247 | BindingDB |
Ki | 1.18 nM | PMID1353247 | BindingDB |
Ki | 1.2 nM | PMID2172775 | BindingDB |
Ki | 1.2 nM | PMID9605427 | BindingDB |
Ki | 1.25893 - 12.5893 nM | PMID7996470, PMID1353247, PMID7908642 | IUPHAR |
Ki | 1.99 nM | PMID10611634 | BindingDB |
Ki | 2.0 nM | PMID10762040 | BindingDB |
Ki | 2.01 nM | PMID10762040 | ChEMBL |
Ki | 3.2 nM | PMID24365159 | ChEMBL |
Ki | 4.59 nM | PMID7996470 | BindingDB |
Ki | 4.6 nM | PMID7562902 | BindingDB,ChEMBL |
Ki | 7.1 nM | PMID15911252 | ChEMBL |
Ki | 7.947 nM | DrugMatrix in vitro pharmacology data | ChEMBL |
Ki | 13.6 nM | PMID7996470 | BindingDB |
Ki | 15.0 nM | PMID17257841 | BindingDB |
Ki | 28.84 nM | PMID24365159 | ChEMBL |
Ki | 77.0 nM | PMID2172775 | BindingDB |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417